Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

First Tracks Biotherapeutics, Inc. (TRAXV)

NASDAQ

$23.08

$--

(0.00%)

First Tracks Biotherapeutics, Inc. (TRAXV) Live Price Chart

Page last updated: 2026-04-10 20:11:00

Key Market Data

Market Cap	$799.22M
Open	$22.84
High	$25.96
Low	$19.00
Previous Close	$23.00
Price Change	--
Percentage Change	0.00%
Volume	14K

First Tracks Biotherapeutics, Inc. (TRAXV) Stock Price Today

First Tracks Biotherapeutics, Inc. (TRAXV) is currently trading at $23.08 as of 2026-04-10 20:11:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned +21.47% over the past four weeks. Over the last 12 months, First Tracks Biotherapeutics, Inc. has recorded a +21.47% price change, indicating a Strong performance relative to the broader market.

First Tracks Biotherapeutics, Inc. (TRAXV) 7-Day Stock Price Changes

Over the past seven days, First Tracks Biotherapeutics, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $20.00 to the latest recorded price of $23.08, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (13,670), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TRAXV has delivered a +21.47% return over the past month and a +21.47% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy First Tracks Biotherapeutics, Inc. (TRAXV)

You can buy and trade TRAXV on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TRAXV and Execute Your Trade

Open the trading page, enter TRAXV in the search bar, select the amount of TRAXV you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is First Tracks Biotherapeutics, Inc. (TRAXV)?

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

Frequently Asked Questions (FAQ)

1.What is the current share price of First Tracks Biotherapeutics, Inc.?

The latest trading price for First Tracks Biotherapeutics, Inc. (Common Stock) is $ 23.08, compared with a previous closing price of $ 23.00. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for TRAXV can be tracked on the live chart and quote section on this page.

2.Is First Tracks Biotherapeutics, Inc. stock going up or down?

Looking at recent performances, TRAXV has returned +21.47% over the past month, +21.47% over the last six months and +21.47% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for First Tracks Biotherapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does TRAXV currently sit relative to its 52-week high and low?

In the most recent 52-week period, First Tracks Biotherapeutics, Inc. has traded between a low of $ 19.00 and a high of $ 25.97. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether TRAXV is currently nearer the top or the bottom of its one-year trading band.

4.How is First Tracks Biotherapeutics, Inc. classified by sector and industry?

First Tracks Biotherapeutics, Inc. is classified in the -- sector. In practice, this means First Tracks Biotherapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing TRAXV’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence First Tracks Biotherapeutics, Inc.’s performance.

5.Where is First Tracks Biotherapeutics, Inc. listed and how large is it by market value?

First Tracks Biotherapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 799.22M, the company is classified as a Small-cap stock. Market cap gives a quick sense of First Tracks Biotherapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does TRAXV's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit First Tracks Biotherapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track First Tracks Biotherapeutics, Inc.'s financial performance over time?

To follow First Tracks Biotherapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TRAXV is performing and how the market is responding.

8.When is First Tracks Biotherapeutics, Inc. expected to report earnings?

First Tracks Biotherapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TRAXV, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in First Tracks Biotherapeutics, Inc.'s earnings reports?

First Tracks Biotherapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TRAXV is meeting, beating or missing expectations.

10.How can I stay informed about First Tracks Biotherapeutics, Inc.'s results and guidance?

You can stay up to date on First Tracks Biotherapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TRAXV on this page helps you see how new information is being reflected in the stock.

11.Does First Tracks Biotherapeutics, Inc. pay a regular cash dividend to its shareholders?

First Tracks Biotherapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TRAXV's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TRAXV?

Based on the latest earnings data, TRAXV has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether First Tracks Biotherapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings First Tracks Biotherapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is First Tracks Biotherapeutics, Inc.?

First Tracks Biotherapeutics, Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TRAXV valued in terms of P/E ratio and EPS?

First Tracks Biotherapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of First Tracks Biotherapeutics, Inc.'s earnings. Comparing TRAXV's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Replimune Group, Inc.

Mawson Infrastructure Group Inc.

MIGI

Hitek Global Inc.

HKIT

Top Gainers

Browse today's leading gainers in the US stock market

Fusemachines Inc.

FUSE

Erayak Power Solution Group Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

TRAXV-to-USD Calculator

Amount

TRAXV

USD

1 TRAXV = 23.08 USD